2 1 Shi Ji Jing Ji Bao Dao·2025-09-22 18:28Core Insights - The report highlights the target price increases for several listed companies from September 15 to September 21, with notable gains for Guizhou Moutai, Hanwang Technology, and Chunli Medical, showing target price increases of 77.12%, 72.37%, and 64.90% respectively [1][2]. Target Price Increases - Guizhou Moutai (600519) received a target price of 2600.00 with a target increase of 77.12% [2] - Hanwang Technology (002362) has a target price of 42.23 with a target increase of 72.37% [2] - Chunli Medical (688236) has a target price of 37.73 with a target increase of 64.90% [2] - Other companies with significant target price increases include Ruipu Biological (300119) at 64.74% and Xindian Software (688232) at 62.82% [2][3]. Broker Recommendations - A total of 510 listed companies received broker recommendations during the same period, with Huqin Technology (603296) and Hengxuan Technology (688608) each receiving 4 recommendations [3][4]. - Chujiang New Material (002171) received 3 recommendations, indicating strong interest in these companies [4]. Rating Adjustments - 15 companies had their ratings increased, including Bertley (603596) upgraded from "Hold" to "Buy" by Caitong Securities [5]. - Other notable upgrades include Placo New Materials (300811) and Dinglong Co., Ltd. (300054), both upgraded to "Buy" [5][6]. Rating Downgrades - 15 companies also experienced rating downgrades, with Jianshi Yuan (603369) downgraded from "Buy" to "Hold" by Zhongtai Securities [6]. - Nova Star Cloud (301589) saw its rating lowered from "Strong Buy" to "Recommended" [6]. First Coverage - During the same period, 92 instances of first coverage were reported, with companies like Rhein Biotech (002166) receiving a "Buy" rating from CITIC Securities [7]. - Other companies receiving initial coverage include Xiamen Port (000905) and China Communications Construction (601800), both rated positively [7].